Clinical Trial Update: Impact of tdrd9 Gene Mutations in the Therapeutic Response to L-carnitine in Oligoasthenozoospermic Men [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigates how tdrd9 gene mutations influence the therapeutic response to L-carnitine in men with oligoasthenozoospermia. The trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Male Infertility
• Oligoasthenozoospermia

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: South Valley University | Conditions: Oligoasthenozoospermia, Male Infertility | Phase 3 | Status: ACTIVE_NOT_RECRUITING